Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 8/2017

01-08-2017 | Rhinology

Effectiveness of quercetin in an experimental rat model of allergic rhinitis

Authors: Mustafa Sagit, Halil Polat, Seren Gulsen Gurgen, Elife Berk, Sabri Guler, Mehmet Yasar

Published in: European Archives of Oto-Rhino-Laryngology | Issue 8/2017

Login to get access

Abstract

We aimed to investigate whether quercetin had a therapeutic effect in an experimental rat model of allergic rhinitis. The study was conducted with 35 rats, which were randomly assigned into 4 groups: group 1 (n = 5), sham group; group 2 (quercetin group, n = 10) received 80 mg/kg day quercetin; group 3 (steroid group, n = 10) received steroid (mometasone furoate); and group 4 (control group, n = 10), received ovalbumin alone. Rats were sensitized by administration of ovalbumin on alternate days over 14 days via an intraperitoneal route. On day 15, in addition to ovalbumin via an intranasal route, quercetin and steroid were given over 7 days to the corresponding groups. All rats were then sacrificed and nasal turbinates were evaluated histopathologically, and serum total IgE and ovalbumin (OVA)-specific IgE values were measured before and after treatment. A significant increase in OVA-specific IgE values was detected in all groups except sham group. A significant increase was detected in post-treatment total IgE levels in the control group, while no significant change was detected in the sham, quercetin, and intranasal steroid groups. On histopathological evaluation, it was observed that findings of allergic rhinitis were suppressed in the quercetin group when compared to the control group. In immunohistochemical evaluation, it was detected that COX-2 and VIP expressions were weaker in the quercetin group compared to the control group. Based on these findings, we conclude that quercetin was effective in allergic rhinitis induced by ovalbumin in rats both histopathologically and serologically.
Literature
1.
go back to reference De S, Fenton JE, Jones AS (2005) Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease. J Laryngol Otol 119:436–442PubMed De S, Fenton JE, Jones AS (2005) Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease. J Laryngol Otol 119:436–442PubMed
2.
go back to reference Nagai H, Teremachi H, Tuchiya T (2006) Recent advances in the development of anti-allergic drugs. Allergol Int 55:35–42CrossRefPubMed Nagai H, Teremachi H, Tuchiya T (2006) Recent advances in the development of anti-allergic drugs. Allergol Int 55:35–42CrossRefPubMed
3.
go back to reference Greiner AN, Meltzer EO (2011) Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. Proc Am Thorac Soc 8:121–131CrossRefPubMed Greiner AN, Meltzer EO (2011) Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. Proc Am Thorac Soc 8:121–131CrossRefPubMed
4.
go back to reference Kayasuga R, Iba Y, Hossen M, Watanabe T, Kamei C (2003) The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice. Int Immunopharmacol 3:469–473CrossRefPubMed Kayasuga R, Iba Y, Hossen M, Watanabe T, Kamei C (2003) The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice. Int Immunopharmacol 3:469–473CrossRefPubMed
5.
go back to reference Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418–425PubMed Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, Van Norren K, Van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418–425PubMed
6.
go back to reference Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T (2011) Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 218:44–52CrossRefPubMed Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T (2011) Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 218:44–52CrossRefPubMed
7.
go back to reference Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–337CrossRefPubMed Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–337CrossRefPubMed
8.
go back to reference Bischoff SC (2008) Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 11:733–740CrossRefPubMed Bischoff SC (2008) Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 11:733–740CrossRefPubMed
9.
go back to reference Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N, Burman AC (2009) Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem 9:138–161CrossRefPubMed Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N, Burman AC (2009) Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem 9:138–161CrossRefPubMed
10.
go back to reference Murakami A, Ashida H, Terao J (2008) Multitargeted cancer prevention by quercetin. Cancer Lett 269:315–325CrossRefPubMed Murakami A, Ashida H, Terao J (2008) Multitargeted cancer prevention by quercetin. Cancer Lett 269:315–325CrossRefPubMed
11.
go back to reference Sagit M, Korkmaz F, Gürgen SG, Gundogdu R, Akcadag A, Ozcan I (2015) Quercetine attenuates the gentamicin-induced ototoxicity in a rat model. Int J Pediatr Otorhinolaryngol 79:2109–2114CrossRefPubMed Sagit M, Korkmaz F, Gürgen SG, Gundogdu R, Akcadag A, Ozcan I (2015) Quercetine attenuates the gentamicin-induced ototoxicity in a rat model. Int J Pediatr Otorhinolaryngol 79:2109–2114CrossRefPubMed
12.
go back to reference Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. II Farmaco 56:683–687CrossRef Guardia T, Rotelli AE, Juarez AO, Pelzer LE (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. II Farmaco 56:683–687CrossRef
13.
go back to reference Avincsal MO, Ozbal S, Ikiz AO, Pekcetin C, Güneri EA (2014) Effects of topical intranasal doxycycline treatment in the rat allergic rhinitis model. Clin Exp Otorhinolaryngol 7:106–111CrossRefPubMedPubMedCentral Avincsal MO, Ozbal S, Ikiz AO, Pekcetin C, Güneri EA (2014) Effects of topical intranasal doxycycline treatment in the rat allergic rhinitis model. Clin Exp Otorhinolaryngol 7:106–111CrossRefPubMedPubMedCentral
14.
go back to reference Wang LF, Xu LJ, Guo FH, Wang LN, Shen XH (2010) Effect of antiallergic herbal agents on chloride channel-3 and immune microenvironment in nasal mucosal epithelia of allergic rhinitis rabbits. Chin Med J 123:1034–1038PubMed Wang LF, Xu LJ, Guo FH, Wang LN, Shen XH (2010) Effect of antiallergic herbal agents on chloride channel-3 and immune microenvironment in nasal mucosal epithelia of allergic rhinitis rabbits. Chin Med J 123:1034–1038PubMed
15.
go back to reference Nabe T, Shimizu K, Mizutani N, Saeki Y, Yamamura H, Takenaka H, Kohno S (1997) A new model of experimental allergic rhinitis using Japanese cedar pollen in guinea pigs. Jpn J Pharmacol 75:243–251CrossRefPubMed Nabe T, Shimizu K, Mizutani N, Saeki Y, Yamamura H, Takenaka H, Kohno S (1997) A new model of experimental allergic rhinitis using Japanese cedar pollen in guinea pigs. Jpn J Pharmacol 75:243–251CrossRefPubMed
16.
go back to reference Kawase M, He F, Kubota A, Hata JY, Kobayakawa SI, Hiramatsu M (2006) Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats. Biosci Biotechnol Biochem 70:3025–3030CrossRefPubMed Kawase M, He F, Kubota A, Hata JY, Kobayakawa SI, Hiramatsu M (2006) Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats. Biosci Biotechnol Biochem 70:3025–3030CrossRefPubMed
17.
go back to reference Ishida M, Amesara R, Ukai K, Sakakura Y (1994) Antigen (DNP-AS)-induced allergic rhinitis model in guinea pigs. Ann Allergy 72:240–244PubMed Ishida M, Amesara R, Ukai K, Sakakura Y (1994) Antigen (DNP-AS)-induced allergic rhinitis model in guinea pigs. Ann Allergy 72:240–244PubMed
18.
go back to reference Guibas GV, Spandou E, Meditskou S, Vyzantiadis TA, Priftis KN, Anogianakis G (2013) N-acetylcysteine exerts therapeutic action in a rat model of allergic rhinitis. Int Forum Allergy Rhinol 7:543–549CrossRef Guibas GV, Spandou E, Meditskou S, Vyzantiadis TA, Priftis KN, Anogianakis G (2013) N-acetylcysteine exerts therapeutic action in a rat model of allergic rhinitis. Int Forum Allergy Rhinol 7:543–549CrossRef
19.
go back to reference Wei WD, Yuan F, Wang JL, Hou YP (2006) Botulinum toxin therapy in the ovalbumin-sensitized rat. Neuroimmunomodulation 14:78–83 Wei WD, Yuan F, Wang JL, Hou YP (2006) Botulinum toxin therapy in the ovalbumin-sensitized rat. Neuroimmunomodulation 14:78–83
20.
go back to reference Sato J, Asakura K, Murakamı M, Uede T, Kataura A (1999) Suppressive effects of CTLA4-Ig on nasal allergic reactions in presensitized murine model. Life Sci 64:785–795CrossRefPubMed Sato J, Asakura K, Murakamı M, Uede T, Kataura A (1999) Suppressive effects of CTLA4-Ig on nasal allergic reactions in presensitized murine model. Life Sci 64:785–795CrossRefPubMed
21.
go back to reference Xu YY, Liu X, Dai LB, Zhou SH (2012) Effect of tong Qiao drops on the expression of eotaxin, IL-13 in the nasal mucosa of rats with allergic rhinitis. J Chin Med Assoc 75:524–529CrossRefPubMed Xu YY, Liu X, Dai LB, Zhou SH (2012) Effect of tong Qiao drops on the expression of eotaxin, IL-13 in the nasal mucosa of rats with allergic rhinitis. J Chin Med Assoc 75:524–529CrossRefPubMed
22.
go back to reference Ohrui T, Funayama T, Sekizawa K, Yamaya M, Sasaki H (1999) Effects of inhaled beclomethasone dipropionate on serum IgE levels and clinical symptoms in atopic asthma. Clin Exp Allergy 29:357–361CrossRefPubMed Ohrui T, Funayama T, Sekizawa K, Yamaya M, Sasaki H (1999) Effects of inhaled beclomethasone dipropionate on serum IgE levels and clinical symptoms in atopic asthma. Clin Exp Allergy 29:357–361CrossRefPubMed
23.
go back to reference Naclerio RM, Adkinson NF, Creticos PS, Baroody FM, Hamilton RG, Norman PS (1993) Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin IE antibodies. J Allergy Clin İmmunol 92:717–721CrossRefPubMed Naclerio RM, Adkinson NF, Creticos PS, Baroody FM, Hamilton RG, Norman PS (1993) Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin IE antibodies. J Allergy Clin İmmunol 92:717–721CrossRefPubMed
24.
go back to reference Nakaya M, Dohi M, Okunishi K, Nakagome K, Tanaka R, Imamura M et al (2007) Prolonged allergen challenge in murine nasal allergic rhinitis: nasal airway remodeling and adaptation of nasal airway responsiveness. Laryngoscope 117:881–885CrossRefPubMed Nakaya M, Dohi M, Okunishi K, Nakagome K, Tanaka R, Imamura M et al (2007) Prolonged allergen challenge in murine nasal allergic rhinitis: nasal airway remodeling and adaptation of nasal airway responsiveness. Laryngoscope 117:881–885CrossRefPubMed
25.
go back to reference Shaida A, Kenyon G, Devalia J (2001) Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 108:791–796CrossRefPubMed Shaida A, Kenyon G, Devalia J (2001) Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 108:791–796CrossRefPubMed
26.
go back to reference Raap U, Braunstahl GJ (2010) The role of neurotrophins in the pathophysiology of allergic rhinitis. Curr Opin Allergy Clin Immunol 10:8–13CrossRefPubMed Raap U, Braunstahl GJ (2010) The role of neurotrophins in the pathophysiology of allergic rhinitis. Curr Opin Allergy Clin Immunol 10:8–13CrossRefPubMed
27.
go back to reference Canonica GW, Tarantini F, Compalati E, Penagos M (2007) Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy 62:359–366CrossRefPubMed Canonica GW, Tarantini F, Compalati E, Penagos M (2007) Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy 62:359–366CrossRefPubMed
28.
go back to reference Iris K, Joachim H, Guenther W et al (2006) Association of carotenoids, tocopherols and vitamin C in plasma with allergic rhinitis and allergic sensitisation in adults. Public Health Nutr 9:472–479 Iris K, Joachim H, Guenther W et al (2006) Association of carotenoids, tocopherols and vitamin C in plasma with allergic rhinitis and allergic sensitisation in adults. Public Health Nutr 9:472–479
29.
go back to reference Ercan I, Cakir BÖ, Başak T et al (2006) Effects of topical application of methotrexate on nasal mucosa in rats: a preclinical assessment study. Otolaryngol Head Neck Surg 134:751–755CrossRefPubMed Ercan I, Cakir BÖ, Başak T et al (2006) Effects of topical application of methotrexate on nasal mucosa in rats: a preclinical assessment study. Otolaryngol Head Neck Surg 134:751–755CrossRefPubMed
30.
go back to reference Middleton E Jr (1998) Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 439:175–182CrossRefPubMed Middleton E Jr (1998) Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 439:175–182CrossRefPubMed
31.
go back to reference Min YD, Choi CH, Bark H et al (2007) Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res 56:210–215CrossRefPubMed Min YD, Choi CH, Bark H et al (2007) Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res 56:210–215CrossRefPubMed
32.
go back to reference Dorsch W, Bittinger M, Kaas A et al (1992) Antiasthmatic effects of Galphimia glauca, gallic acid, and related compounds prevent allergen- and platelet-activating factor-induced bronchial obstruction as well as bronchial hyperreactivity in guinea pigs. Int Arch Allergy Immunol 97:1–7CrossRefPubMed Dorsch W, Bittinger M, Kaas A et al (1992) Antiasthmatic effects of Galphimia glauca, gallic acid, and related compounds prevent allergen- and platelet-activating factor-induced bronchial obstruction as well as bronchial hyperreactivity in guinea pigs. Int Arch Allergy Immunol 97:1–7CrossRefPubMed
33.
go back to reference Rogerio AP, Kanashiro A, Fontanari C et al (2007) Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 56:402–408CrossRefPubMed Rogerio AP, Kanashiro A, Fontanari C et al (2007) Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 56:402–408CrossRefPubMed
34.
go back to reference Sakaı-KM Asano K (2013) Inhibitory action of quercetin on eosinophil activation in vitro. Evid Based Complement Altern Med 2013:127105. doi:10.1155/2013/127105 Sakaı-KM Asano K (2013) Inhibitory action of quercetin on eosinophil activation in vitro. Evid Based Complement Altern Med 2013:127105. doi:10.​1155/​2013/​127105
35.
go back to reference Ohashi Y, Nakai Y, Kihara S, Ikeoka H, Takano H, Imoto T (1985) Ciliary activity in patients with nasal allergies. Arch Otorhinolaryngol 242:141–147CrossRefPubMed Ohashi Y, Nakai Y, Kihara S, Ikeoka H, Takano H, Imoto T (1985) Ciliary activity in patients with nasal allergies. Arch Otorhinolaryngol 242:141–147CrossRefPubMed
36.
go back to reference Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108:2–8CrossRef Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108:2–8CrossRef
37.
go back to reference Zhang S, Smith N, Schuster D et al (2011) Quercetin increases CFTR mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis. Am J Rhinol Allergy 25:307–312CrossRefPubMedPubMedCentral Zhang S, Smith N, Schuster D et al (2011) Quercetin increases CFTR mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis. Am J Rhinol Allergy 25:307–312CrossRefPubMedPubMedCentral
Metadata
Title
Effectiveness of quercetin in an experimental rat model of allergic rhinitis
Authors
Mustafa Sagit
Halil Polat
Seren Gulsen Gurgen
Elife Berk
Sabri Guler
Mehmet Yasar
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 8/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4602-z

Other articles of this Issue 8/2017

European Archives of Oto-Rhino-Laryngology 8/2017 Go to the issue